Description

2-(4-Bromo-Phenyl)-5-Methyl-4,5,6,7-Tetrahydro-Oxazolo[4,5-C]Pyridine is a high-purity, advanced pharmaceutical intermediate characterized by its fused oxazolo-pyridine heterocyclic structure. This compound matters as a critical building block in modern medicinal chemistry, enabling the synthesis of novel, targeted therapeutic agents. It is primarily needed by research institutions and pharmaceutical companies engaged in the development of new drug candidates, particularly within central nervous system (CNS) and oncology research pipelines.

Application

• Pharmaceutical Intermediate: Serves as a key synthetic precursor in the research and development of new active pharmaceutical ingredients (APIs).
• Medicinal Chemistry Research: Used as a core scaffold for constructing compound libraries in high-throughput screening and structure-activity relationship (SAR) studies.
• CNS Drug Development: Employed in the synthesis of potential therapeutics targeting neurological disorders, leveraging its heterocyclic framework.
• Oncological Research: Acts as a building block for novel kinase inhibitors and other targeted cancer therapies.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations providing custom synthesis and process development services.
• Academic Research: Utilized in university and institutional labs for fundamental studies in organic synthesis and heterocyclic chemistry.

Basic Information

Product Name	2-(4-Bromo-Phenyl)-5-Methyl-4,5,6,7-Tetrahydro-Oxazolo[4,5-C]Pyridine
CAS No.	1017781-96-2
Molecular Formula	C15H15BrN2O
Molecular Weight	319.20 g/mol
Synonyms	5-Methyl-2-(4-bromophenyl)-4,5,6,7-tetrahydrooxazolo[4,5-c]pyridine; 2-(4-Bromophenyl)-5-methyl-4,5,6,7-tetrahydro[1,3]oxazolo[4,5-c]pyridine; 4,5,6,7-Tetrahydro-5-methyl-2-(4-bromophenyl)oxazolo[4,5-c]pyridine; Oxazolo[4,5-c]pyridine, 4,5,6,7-tetrahydro-2-(4-bromophenyl)-5-methyl-; 1017781-96-2; Bromo-phenyl tetrahydro-oxazolopyridine derivative
EINECS	Contact for details

Quality Control

Our 2-(4-Bromo-Phenyl)-5-Methyl-4,5,6,7-Tetrahydro-Oxazolo[4,5-C]Pyridine is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry, to ensure it meets the high standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and analytical methods is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). Keep away from strong bases and incompatible organic solvents. For long-term storage, consider inert atmosphere conditions to ensure stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (HPLC)	Conforms
Identification (IR)	Conforms to reference spectrum
Purity (HPLC)	≥ 98.0%
Single Maximum Impurity (HPLC)	≤ 1.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.